Shanghai RAAS Blood Products Co., Ltd. (002252.SZ)
CNY 7.23
(-0.41%)
CNY 7.23
(-0.41%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 2.35 Billion | 1.72 Billion | 1.29 Billion | 1.16 Billion | 872.69 Million | 262.5 Million |
| Net Income | 1.77 Billion | 1.87 Billion | 1.28 Billion | 1.31 Billion | 605.92 Million | -1.52 Billion |
| Depreciation & Amortization | 172.05 Million | 184.52 Million | 159.03 Million | 152.75 Million | 148.46 Million | 149.75 Million |
| Deferred income taxes | 2.88 Million | 19.61 Million | -9.66 Million | 73.1 Million | 33.44 Million | -310.78 Million |
| Stock-based compensation | 21.6 Million | -19.61 Million | 9.66 Million | -73.1 Million | -33.44 Million | - |
| Change in working capital | 194.71 Million | -39.73 Million | -137.28 Million | 92.67 Million | -110.08 Million | -708.44 Million |
| Other non-cash items | 354.1 Million | -292.19 Million | -16.67 Million | -395.17 Million | 228.39 Million | 2.34 Billion |
| Investing Cash Flow | -789.68 Million | -1.13 Billion | -730.81 Million | -608.73 Million | -152.33 Million | 677.83 Million |
| Investments in PPE | -450.79 Million | -225.72 Million | -204.6 Million | -251.76 Million | -154.83 Million | -156.93 Million |
| Acquisitions | -482.77 Million | 2.23 Million | 3.19 Million | 9.02 Million | -285.66 Thousand | - |
| Investment purchases | -1.24 Billion | -1.44 Billion | -779.61 Million | -390.92 Million | -21.6 Million | -224.8 Million |
| Sales/Maturities of investments | 1.38 Billion | 536.65 Million | 252.81 Million | 36.38 Million | 17.9 Million | 1.05 Billion |
| Other Investing Activities | 2.16 Million | 1.48 Million | -2.6 Million | -11.45 Million | 6.48 Million | 774.7 Thousand |
| Financing Cash Flow | -1.09 Billion | -193.37 Million | -179.27 Million | -58.84 Million | -150.43 Million | -1.46 Billion |
| Debt repayment | -2.04 Million | -5.73 Million | -7.74 Million | -7.74 Million | -150 Million | -1.75 Billion |
| Dividends payments | -202.22 Million | -188.74 Million | -168.54 Million | -67.4 Million | -1.59 Million | -166.58 Million |
| Common Stock Repurchased | -999.99 Million | - | - | - | - | - |
| Common Stock Issuance | 113.17 Million | - | - | - | - | - |
| Other Financing Activities | -202.22 Million | 1.09 Million | -2.98 Million | 16.67 Million | 1.15 Million | 458.22 Million |
| Accounts receivables | 163.23 Million | -286.96 Million | -75.15 Million | 253.85 Million | 89.99 Million | 133.76 Million |
| Accounts payables | 449.22 Million | 333.93 Million | 961.09 Million | 24.96 Million | 7.33 Million | 13.01 Million |
| Inventory | -417.73 Million | -106.31 Million | -1.01 Billion | -259.25 Million | -240.86 Million | -544.45 Million |
| Other working capital | 452.11 Million | 19.61 Million | -9.66 Million | 73.1 Million | 33.44 Million | -163.99 Million |
| Cash at beginning of period | 2.73 Billion | 2.31 Billion | 1.93 Billion | 1.43 Billion | 864.02 Million | 1.38 Billion |
| Cash at end of period | 3.2 Billion | 2.72 Billion | 2.31 Billion | 1.93 Billion | 1.43 Billion | 864.02 Million |
| Capital Expenditure | -450.79 Million | -225.72 Million | -204.6 Million | -251.76 Million | -154.83 Million | -156.93 Million |
| Effect of forex changes on cash | -3.3 Million | 11.75 Million | -2.26 Million | -4.76 Million | 653.93 Thousand | 2.2 Million |
| Net cash flow / Change in cash | 470.81 Million | 413.77 Million | 381.65 Million | 496.51 Million | 570.58 Million | -521.81 Million |
| Free Cash Flow | 1.9 Billion | 1.49 Billion | 1.08 Billion | 917.08 Million | 717.85 Million | 105.56 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 597 Million | 483.98 Million | 756.81 Million | 1.77 Billion | -8.12 Million | 548.6 Million |
| Depreciation & Amortization | - | 58.51 Million | 58.51 Million | 172.05 Million | 42.49 Million | -79.44 Million |
| Deferred income taxes | - | - | - | 2.88 Million | - | - |
| Stock-based compensation | - | - | - | 21.6 Million | 21.6 Million | - |
| Change in working capital | - | -390.81 Million | - | 194.71 Million | -254.5 Million | -333.74 Million |
| Other non-cash items | -17.38 Million | -1.21 Billion | 49.76 Million | 354.1 Million | 397.54 Million | 371.59 Million |
| Investing Cash Flow | -88.27 Million | -1.23 Billion | 112.87 Million | -789.68 Million | -726.07 Million | 471.58 Million |
| Investments in PPE | -113.07 Million | -109.22 Million | -100.54 Million | -450.79 Million | -85 Million | -203.12 Million |
| Acquisitions | 34.09 Million | -33.22 Million | 43.09 Thousand | -482.77 Million | -483.05 Million | 80.99 Thousand |
| Investment purchases | -718.32 Million | -1.26 Billion | -371.13 Million | -1.24 Billion | -220.49 Million | -117.29 Million |
| Sales/Maturities of investments | 741 Million | 171.66 Million | 584.35 Million | 1.38 Billion | 61.39 Million | 790.99 Million |
| Other Investing Activities | 2.11 Million | -512.96 Thousand | 156.19 Thousand | 2.16 Million | 1.08 Million | 920 Thousand |
| Financing Cash Flow | -221.83 Million | -190.36 Million | -8.57 Million | -1.09 Billion | -2.2 Million | -939.5 Million |
| Debt repayment | - | -2.63 Million | -2.63 Million | -2.04 Million | - | - |
| Dividends payments | -229.44 Million | -190.04 Million | -4.18 Million | -202.22 Million | - | -52.98 Million |
| Common Stock Repurchased | - | - | - | -999.99 Million | -999.99 Million | - |
| Common Stock Issuance | - | - | - | 113.17 Million | 113.17 Million | - |
| Other Financing Activities | 7.61 Million | -186.95 Million | -8.57 Million | -202.22 Million | 886.66 Million | -886.51 Million |
| Accounts receivables | - | -369.96 Million | - | 163.23 Million | 163.23 Million | -228.57 Million |
| Accounts payables | - | - | - | 449.22 Million | - | - |
| Inventory | - | -20.85 Million | - | -417.73 Million | -417.73 Million | -105.17 Million |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 1.89 Billion | 4.92 Billion | 3.2 Billion | 2.73 Billion | 4.02 Billion | 3.54 Billion |
| Cash at end of period | 2.14 Billion | 1.89 Billion | 4.92 Billion | 3.2 Billion | 3.2 Billion | 3.58 Billion |
| Capital Expenditure | -113.07 Million | -109.22 Million | -100.54 Million | -450.79 Million | -85 Million | -203.12 Million |
| Effect of forex changes on cash | -2.84 Million | 544.05 Thousand | 136.14 Thousand | -3.3 Million | -3.25 Million | -255.01 Thousand |
| Net cash flow / Change in cash | 250.22 Million | -3.03 Billion | 1.72 Billion | 470.81 Million | -819.25 Million | 38.83 Million |
| Free Cash Flow | 466.55 Million | -896.41 Million | 706.03 Million | 1.9 Billion | 261.91 Million | 303.88 Million |
FRRPF
300690
066575
DPLS
011930
301021